Tag

2 results found for: prescribing review

What's the cost of NHS savings?

NHS England’s review of “low value” prescription items has the potential to save up to £400 million a year, but what could be the implications?

Reasons to welcome the prescribing review

What’s been happening under cover with prescribing is now out in the open, says Noel Wicks It seems that NHS England is taking a leaf out of the book of certain CCGs with its recent announcement to review a selection of “low value” medicines that it believes may have limited clinical value. The 10 items include tadalafil, travel vaccines, lidocaine plasters, fentanyl and doxazosin. In total, this could yield about £130 million in savings, although I imagine this assumes that no alternatives are prescribed. This seems a far cry from the £400 million that Simon Stevens suggested could be saved by this review. So where is the rest coming from? Alongside this initial list of specified medicines NHS England also intends review other areas such as gluten-free foods and minor ailments including hayfever, pain and indigestion.

Latest News

SMEs looking to spend more on marketing in 2018/19

Many small businesses are looking to up their marketing spend in the next financial year, with the average SME plan...

Don’t miss nomination deadline, NPA urges

The NPA has issued a call for members to nominate a candidate for the forthcoming board of management elections by ...

Views

Why we can't continue to work harder and harder

Workload pressure isn't going to change, but how we work with it can, suggests Noel Wicks. The recent media spotli...

Popular Features

Pharmacy Winter action – take to social media today!

Pharmacy teams are being asked to join in with today's #pharmacywinter action day

Dispensing errors defence approved by Parliament

MPs unanimously passed a long-awaited measure that will protect pharmacists from prosecution for inadvertent dispensing ...

Boots rolls out affordable EHC business-wide

Boots has said that it now stocks a more affordable morning after pill in all its UK stores, explaining that  supply ch...